Due to the observational design of the included studies in this review, causality between visfatin and NAFLD, hepatic steatosis, liver fibrosis, lobar inflammation, and NASH cannot be confirmed or negated. This evidence concerns the gene NAMPT and metabolic dysfunction-associated steatohepatitis.